During the past decade, Mito Kyodo General Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mito Kyodo General Hospital" #1 sponsor was "Bayer" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Allergan" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "H. Lundbeck A/S" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Mito Kyodo General Hospital" are "Anemia" (4 trials), "Renal Insufficiency, Chronic" (4 trials), "Migraine" (3 trials), "Clostridium Difficile Infection" (1 trials) and "Diabetic Mellitus" (1 trials). Many other conditions were trialed in "Mito Kyodo General Hospital" in a lesser frequency.

Most popular intervention types in "Mito Kyodo General Hospital" are "Drug" (10 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Molidustat (BAY85-3934)" (4 trials), "Placebo" (4 trials), "Darbepoetin alfa" (3 trials), "Abicipar Pegol" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mito Kyodo General Hospital" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Mito Kyodo General Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Mito Kyodo General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mito Kyodo General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".